This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2016 Jul 28;375(4):357-68.

doi: 10.1056/NEJMra1604339.

Treatment of Opioid-Use Disorders

Marc A Schuckit¹

Affiliations

PMID: 27464203
DOI: 10.1056/NEJMra1604339

Free article

Review

Treatment of Opioid-Use Disorders

Marc A Schuckit. N Engl J Med. 2016.

Free article

. 2016 Jul 28;375(4):357-68.

doi: 10.1056/NEJMra1604339.

Author

Marc A Schuckit¹

Affiliation

¹ From the Department of Psychiatry, University of California, San Diego, La Jolla.

PMID: 27464203
DOI: 10.1056/NEJMra1604339

No abstract available

PubMed Disclaimer

Comment in

Treatment of Opioid-Use Disorders.
Schuckit MA. Schuckit MA. N Engl J Med. 2016 Oct 20;375(16):1596-1597. doi: 10.1056/NEJMc1610830. N Engl J Med. 2016. PMID: 27797302 No abstract available.
Treatment of Opioid-Use Disorders.
Winetsky D, Weinrieb RM, Perrone J. Winetsky D, et al. N Engl J Med. 2016 Oct 20;375(16):1596. doi: 10.1056/NEJMc1610830. N Engl J Med. 2016. PMID: 27797303 No abstract available.
Treatment of Opioid-Use Disorders.
Benumof JL. Benumof JL. N Engl J Med. 2016 Oct 20;375(16):1596. doi: 10.1056/NEJMc1610830. N Engl J Med. 2016. PMID: 28103430 No abstract available.

Similar articles

"Should I stay or should I go?" Coming off methadone and buprenorphine treatment.
Winstock AR, Lintzeris N, Lea T. Winstock AR, et al. Int J Drug Policy. 2011 Jan;22(1):77-81. doi: 10.1016/j.drugpo.2010.08.001. Epub 2010 Oct 16. Int J Drug Policy. 2011. PMID: 20956077
Opioid dependence: rationale for and efficacy of existing and new treatments.
Fiellin DA, Friedland GH, Gourevitch MN. Fiellin DA, et al. Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S173-7. doi: 10.1086/508180. Clin Infect Dis. 2006. PMID: 17109303 Review.
Opioid Use Disorder and Incarceration - Hope for Ensuring the Continuity of Treatment.
Binswanger IA. Binswanger IA. N Engl J Med. 2019 Mar 28;380(13):1193-1195. doi: 10.1056/NEJMp1900069. Epub 2019 Feb 27. N Engl J Med. 2019. PMID: 30811904 No abstract available.
Opioid dependence treatment: options in pharmacotherapy.
Stotts AL, Dodrill CL, Kosten TR. Stotts AL, et al. Expert Opin Pharmacother. 2009 Aug;10(11):1727-40. doi: 10.1517/14656560903037168. Expert Opin Pharmacother. 2009. PMID: 19538000 Free PMC article. Review.
Phenobarbital for alcohol withdrawal in the context of the opioid epidemic: a neglected caveat.
Terasaki D, Kulick B, Calcaterra S, Ray L. Terasaki D, et al. Addiction. 2023 Jul;118(7):1198-1200. doi: 10.1111/add.16194. Epub 2023 Apr 10. Addiction. 2023. PMID: 36967706 Free PMC article.

See all similar articles

Cited by

Morphine self-administration is inhibited by the antioxidant N-acetylcysteine and the anti-inflammatory ibudilast; an effect enhanced by their co-administration.
Quintanilla ME, Morales P, Santapau D, Gallardo J, Rebolledo R, Riveras G, Acuña T, Herrera-Marschitz M, Israel Y, Ezquer F. Quintanilla ME, et al. PLoS One. 2024 Oct 29;19(10):e0312828. doi: 10.1371/journal.pone.0312828. eCollection 2024. PLoS One. 2024. PMID: 39471200 Free PMC article.
RREACT: A mobile multidisciplinary response to overdose.
Ulintz AJ, McCloskey RJ, Hammond GC, Parrish M, Toliver I, Sharafutdinova A, Lyons MS. Ulintz AJ, et al. J Community Saf Well Being. 2024;9(1):19-26. doi: 10.35502/jcswb.360. Epub 2024 Mar 14. J Community Saf Well Being. 2024. PMID: 39355335 Free PMC article.
A genome-wide Association study of the Count of Codeine prescriptions.
Song W, Lam M, Liu R, Simona A, Weiner SG, Urman RD, Mukamal KJ, Wright A, Bates DW. Song W, et al. Sci Rep. 2024 Oct 1;14(1):22780. doi: 10.1038/s41598-024-73925-4. Sci Rep. 2024. PMID: 39354046 Free PMC article.
Is peer support a tipping point for the opioid use disorder crisis in Appalachia? Research holds the answer.
Horn K, Mathis SM, Nagle L, Hagaman A, Dunkenberger MB, Pack R. Horn K, et al. Harm Reduct J. 2024 Jun 25;21(1):122. doi: 10.1186/s12954-024-01041-7. Harm Reduct J. 2024. PMID: 38914988 Free PMC article.
Pharmacologic profile of ITI-333: a novel molecule for treatment of substance use disorders.
Snyder GL, Li P, Martin T, Zhang L, Yao W, Zheng H, Maguire DR, Gerak LR, Vanover KE, France CP, Davis R. Snyder GL, et al. Psychopharmacology (Berl). 2024 Jul;241(7):1477-1490. doi: 10.1007/s00213-024-06578-w. Epub 2024 May 6. Psychopharmacology (Berl). 2024. PMID: 38710856 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information